Project details

Overview

Project title

RFP-DAN-2020-503251 for mOPV2 Bulk and possible conversion into finished product

Country Programme / Action Plan
Request for proposal
21 Nov 2020

Published

21 November 2020

Deadline

15 January 2021

Budget

 


Procurement type

Services, Supplies

Reference

UNICEFZ219345

Funding Agency

UNICEF - United Nations Children’s Fund, WHO - World Health Organization


Estimated duration

60 months


Countries

Afghanistan, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, British Indian Ocean Territory, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Colombia, Comoros, Congo (Brazaville), Congo, Democratic Republic of the, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, East Timor, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Polynesia, Gabon, Gambia, The, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe (France), Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hong Kong (China), Hungary, Iceland, India, Indonesia, Iran Islamic Republic, Iraq, Ireland, Israel, Italy, Ivory Coast, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Korea, North, Korea, South, Kosovo, Kuwait, Kyrgyz Republic, Laos, Latvia, Lebanon, Lesotho, Liberia, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique (France), Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Federated States of, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, Netherlands Antilles, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, North Macedonia, Norway, Oman, Pakistan, Palau, Palestine / West Bank and Gaza, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn Island, Poland, Portugal, Puerto Rico, Qatar, Reunion (France), Romania, Russian Federation, Rwanda, Saint Helena, Saint Kitts and Nevis, Saint Lucia, Saint Pierre and Miquelon, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Svalbard and Jan Mayen Islands, Swaziland / Kingdom of Eswatini, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Togo, Tokelau, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela, Virgin Islands (British), Virgin Islands (USA), Wallis and Futuna, Western Sahara, Yemen, Zimbabwe

RFP-DAN-2020-503251 for mOPV2 Bulk and possible conversion into finished product

UNICEF

Reference: RFP-DAN-2020-503251

Beneficiary country(ies): Multiple destinations (see 'Countries' tab below)

Registration level: Basic


Deadline on: 15-Jan-2021 00:00 (GMT 1.00) Brussels, Copenhagen, Madrid, Paris


UNITED NATIONS CHILDREN'S FUND (UNICEF)

Wishes to receive Proposals from Manufacturers

For the period January 2021 until December 2025

Monovalent (Sabin) Oral Polio Vaccine type 2 in Bulk Form, potential

Conversion into Finished Product and Delivery, including the Services for

Storage, Management, and Maintenance in a Global Stockpile


PURPOSE

In its capacity as procurement agency for the Global Polio Eradication Initiative (GPEI) and upon request from WHO, UNICEF wishes to enter into a Contract for Products and Services for the supply of one billion doses of monovalent Oral Polio Vaccine type 2 (mOPV2) in bulk form, and the storage, management and maintenance of the same with the Supplier. Should there be a requirement for delivery of a finished product, the Supplier shall convert part or all of the bulk into finished product, store, manage and maintain the finished product, and eventually deliver a WHO prequalified mOPV2 vaccine.

The mOPV2 bulk vaccine is intended to become part of the Global Bulk Stockpile to be stored with the Supplier for potential release by UNICEF for processing into finished product mOPV2.

In case the expiry date of the bulk is beyond the duration of the Request for Proposal (RFP), or any mOPV2 in finished product converted upon request by UNICEF on behalf of WHO, UNICEF may request the Supplier to extend any resulting Contract.


Hyperlinks to Related Project Dossiers:

https://www.ungm.org/Public/Notice/118260

List of countries

http://www.assortis.com/public/files/UNregion.docx